SMALL CELL LUNG CANCER (SCLC)
Clinical trials for SMALL CELL LUNG CANCER (SCLC) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER (SCLC) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER (SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough lung cancer: tarlatamab takes on standard care in phase 3 trial
Disease control OngoingThis phase 3 study compares the experimental drug tarlatamab to standard treatments in 509 adults with small cell lung cancer that returned after initial chemotherapy. The main goal is to see if tarlatamab helps people live longer. Participants must have measurable disease and ha…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
New drug shows promise against aggressive lung cancer
Disease control OngoingThis study tests different doses of tarlatamab in 252 adults with small cell lung cancer that has worsened after one round of chemotherapy. The goal is to see if the drug can shrink tumors or stop the cancer from growing. Tarlatamab is an immunotherapy that helps the immune syste…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
New hope for advanced cancers: immunotherapy drug shows promise in large trial
Disease control OngoingThis study tests the drug pembrolizumab in about 1,600 people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug can shrink tumors and to identify biomarkers that predict response. Participants receive pembrolizumab and are m…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
Radioactive drug targets tough lung cancers in early trial
Disease control OngoingThis early-phase study tests a new radioactive drug (225Ac-ABD147) in people with small cell lung cancer or large cell neuroendocrine carcinoma of the lung that has progressed after platinum-based chemotherapy. The main goals are to check safety, find the best dose, and see initi…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1 • Sponsor: Abdera Therapeutics Inc. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Can strong muscles help lung cancer patients tolerate treatment better?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how muscle mass, strength, and function relate to treatment side effects, quality of life, and survival in people with lung cancer. Researchers will follow 160 patients to understand why some struggle to complete their cancer therapy. The goal is to find ways …
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Sponsor: Zealand University Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:15 UTC